Concepedia

Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer

Laura J. Havrilesky, Angeles A. Alvarez, Robyn Sayer, Johnathan M. Lancaster, John T. Soper, Andrew Berchuck, Daniel L. Clarke‐Pearson, Gustavo C. Rodriguez, Michael E. Carney

Gynecologic Oncology · 2002 · 74 citations · 28 references

DOI

Concepts

References

28

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

, , +16

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Alan N. Gordon, John Fleagle, David Guthrie et al. · Journal of Clinical Oncology · 2001 · 1.2K citations

, , +16

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

Peter G. Rose, John A. Blessing, Andrew R. Mayer et al. · Journal of Clinical Oncology · 1998 · 403 citations

, , +17

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.

G.J.S. Rustin, Ann E. Nelstrop, Patrick McClean et al. · Journal of Clinical Oncology · 1996 · 380 citations

, , +15

Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer

Alan N. Gordon, C.O. Granai, Peter G. Rose et al. · Journal of Clinical Oncology · 2000 · 343 citations

, , +17